News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Licenses Recombineering Technology From Gene Bridges GmbH


10/7/2008 10:16:44 AM

HEIDELBERG, Germany--(BUSINESS WIRE)--Gene Bridges GmbH, the recombineering company, today announced that Takeda Pharmaceutical Company Limited of Osaka, Japan has completed a commercial license agreement for the use of the Red/ET recombination technology from Gene Bridges.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES